Published in Plast Reconstr Surg on January 01, 1995
Periprosthetic tuberculous breast infection. J R Soc Med (2003) 0.80
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med (1999) 5.82
Bacteriology of human and animal bite wounds. J Clin Microbiol (1978) 2.66
Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol (1991) 2.59
Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol (1989) 2.24
Saccharomyces cerevisiae infections in man. Sabouraudia (1984) 1.76
Evaluation of a novel specimen transport system (Venturi Transystem) for anaerobic bacteria. Clin Infect Dis (1997) 1.75
Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin. Antimicrob Agents Chemother (1981) 1.73
Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg (1967) 1.72
Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. J Clin Microbiol (1997) 1.68
Role of anaerobic bacteria in bite-wound infections. Rev Infect Dis (1984) 1.66
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals. Antimicrob Agents Chemother (1985) 1.56
Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50
Characterization of a beta-lactamase from Clostridium clostridioforme. J Antimicrob Chemother (1994) 1.47
Survival of aerobic and anaerobic bacteria in purulent clinical specimens maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul transport systems. J Clin Microbiol (2000) 1.41
Susceptibility of Eikenella corrodens to ten cephalosporins. Antimicrob Agents Chemother (1978) 1.35
Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. Antimicrob Agents Chemother (1978) 1.32
Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles. Clin Infect Dis (1996) 1.31
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. Antimicrob Agents Chemother (1996) 1.27
Frequency of isolation of Porphyromonas species from infected dog and cat bite wounds in humans and their characterization by biochemical tests and arbitrarily primed-polymerase chain reaction fingerprinting. Clin Infect Dis (1996) 1.26
Eikenella corrodens in hand infections. J Hand Surg Am (1983) 1.24
Effect of carbon dioxide on erythromycin. Antimicrob Agents Chemother (1983) 1.21
Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity. Am J Med (1987) 1.21
Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species. J Clin Microbiol (1990) 1.21
Management of human and animal bite wounds. Emerg Med Clin North Am (1985) 1.21
Bone grafts for nasal reconstruction. Plast Reconstr Surg (1982) 1.19
Dog bite wounds and infection: a prospective clinical study. Ann Emerg Med (1980) 1.19
Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics. Antimicrob Agents Chemother (1980) 1.18
Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy. Antimicrob Agents Chemother (1986) 1.16
Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur J Clin Microbiol Infect Dis (2000) 1.14
Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol (1995) 1.12
Identification and strain differentiation of 'Bacteroides fragilis group' species and Prevotella bivia by PCR fingerprinting. Anaerobe (1995) 1.12
New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds. J Med Microbiol (1998) 1.11
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections. Antimicrob Agents Chemother (1985) 1.11
Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rods. J Clin Microbiol (1998) 1.10
Ligandinuria in nephrotoxic acute tubular necrosis. Kidney Int (1977) 1.10
Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother (1983) 1.09
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother (1986) 1.08
A selective medium for Fusobacterium spp. J Appl Bacteriol (1991) 1.07
Infections following clenched-fist injury: a new perspective. J Hand Surg Am (1978) 1.05
Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens. Antimicrob Agents Chemother (1983) 1.04
Isolation of Eikenella corrodens from pulmonary infections. Am Rev Respir Dis (1979) 1.03
Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract. Am J Med (1987) 1.03
Legionnaires' disease. A cause of severe abscess-forming pneumonia. Am J Med (1979) 1.02
Bacteriology of rattlesnake venom and implications for therapy. J Infect Dis (1979) 1.02
Recurrent basal cell carcinoma. A review concerning the incidence, behavior, and management of recurrent basal cell carcinoma, with emphasis on the incompletely excised lesion. Plast Reconstr Surg (1980) 1.01
Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species. Antimicrob Agents Chemother (1990) 1.00
Survival of anaerobic bacteria in various thioglycolate and chopped meat broth formulations. J Clin Microbiol (1995) 1.00
Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis (1993) 0.99
Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin. Int J Dermatol (1987) 0.99
Staphylococcus intermedius: clinical presentation of a new human dog bite pathogen. Ann Emerg Med (1989) 0.97
Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Arch Intern Med (1986) 0.97
Susceptibility of Eikenella corrodens to newer and older quinolones. Antimicrob Agents Chemother (1986) 0.97
Human babesiosis. Clinical and therapeutic considerations. JAMA (1982) 0.95
Assessment of the excess risk of Salmonella dublin infection associated with the use of certified raw milk. Public Health Rep (1988) 0.93
Development of microcirculation in full thickness autogenous skin grafts in mice. Am J Physiol (1967) 0.93
Aerobic bacterial oral flora of garter snakes: development of normal flora and pathogenic potential for snakes and humans. J Clin Microbiol (1981) 0.93
Infectious complications and therapy of bite wounds. J Am Podiatr Med Assoc (1989) 0.92
Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans. J Clin Microbiol (1997) 0.91
Sinus infection due to Eikenella corrodens. Arch Otolaryngol (1978) 0.91
The microcirculatory events within full-thickness skin allografts (homografts) in mice. Surgery (1969) 0.90
Effect of control programs on cefazolin prescribing in a teaching hospital. Am J Hosp Pharm (1979) 0.90
Use of the nasolabial flap for reconstruction of the floor of the mouth. Am J Surg (1978) 0.90
Prevalence of Eikenella corrodens in dental plaque. J Clin Microbiol (1983) 0.90
Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med (1981) 0.90
The elements of medical malpractice: an overview. Clin Infect Dis (1996) 0.90
The standard of care is not so standard. Clin Infect Dis (1997) 0.88
Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins. Antimicrob Agents Chemother (1984) 0.88
Heterotopic brain in the nasopharynx and soft palate: report of two cases. Surgery (1967) 0.88
Pasteurella multocida subsp. multocida and P. multocida subsp. septica differentiation by PCR fingerprinting and alpha-glucosidase activity. J Clin Microbiol (2001) 0.88
Common bacterial skin infections. Diagnostic clues and therapeutic options. Postgrad Med (1993) 0.88
Infections caused by Actinomyces viscosus. Am J Clin Pathol (1981) 0.87
Occurrence of Bacteroides fragilis enterotoxin gene-carrying strains in Germany and the United States. J Clin Microbiol (2000) 0.87
Surgical management and reconstruction of extensive chest wall malignancies. Am J Surg (1982) 0.87
Bilophila wadsworthia isolates from clinical specimens. Clin Infect Dis (1995) 0.87
Duplication of the mandible. Plast Reconstr Surg (1979) 0.87
Potential of topical norfloxacin therapy. Comparative in vitro activity against clinical ocular bacterial isolates. Arch Ophthalmol (1987) 0.86
Surgical correction of late sequelae from facial bone fractures. Am J Surg (1987) 0.86
In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria. Int J Antimicrob Agents (2000) 0.86
Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria. J Infect Dis (1991) 0.85
A silicone gel phantom suitable for multimodality imaging. Invest Radiol (1987) 0.84
Comparative growth of Eikenella corrodens on 15 media in three atmospheres of incubation. J Clin Microbiol (1981) 0.84
Microsurgical transplantation of the rabbit ear with mature transparent chamber. Plast Reconstr Surg (1970) 0.84
Susceptibility of Gardnerella vaginalis to cephradine. Antimicrob Agents Chemother (1983) 0.84
Standards of photography. Plast Reconstr Surg (1984) 0.83
Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial. Am J Med (1987) 0.83
Ciprofloxacin as treatment for genitourinary tract infection. J Urol (1989) 0.82
The oral administration of MnCl2: a potential alternative to IV injection for tissue contrast enhancement in magnetic resonance imaging. Magn Reson Imaging (1984) 0.82
Adverse reactions associated with pentamidine isethionate in AIDS patients: recommendations for monitoring therapy. Drug Intell Clin Pharm (1986) 0.82
Empyema due to Bacteroides gracilis: case report and in vitro susceptibilities to eight antimicrobial agents. Clin Infect Dis (1993) 0.82
Bilophila wadsworthia clinical isolates compared by polymerase chain reaction fingerprinting. Clin Infect Dis (1997) 0.82
Erythromycin for anaerobic pleuropulmonary and soft-tissue infections. JAMA (1979) 0.81
Babesiosis: problems in diagnosis using autoanalyzers. Am J Clin Pathol (1985) 0.81
Surgical management of silicone mastitis. Plast Reconstr Surg (1979) 0.81
Fever in a couple vacationing in the mountains of southern California. Clin Infect Dis (1992) 0.81
Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States. Clin Infect Dis (1997) 0.81
Failure of vancomycin prophylaxis and treatment for Actinobacillus actinomycetemcomitans endocarditis. Antimicrob Agents Chemother (1986) 0.81
Characterization of Bacteroides forsythus strains from cat and dog bite wounds in humans and comparison with monkey and human oral strains. J Clin Microbiol (1999) 0.81
Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents. Rev Infect Dis (1983) 0.81
Correction of contour defects of the face with dermal and dermal-fat grafts. Arch Surg (1972) 0.80